Development of pleural empyema with or without bronchopleural fistula following pneumonectomy presents a major complication with a mortality of 10 to 20%. The surgical goals of bronchopleural fistula treatment are infection control, pus drainage, and lung re-expansion. The main goal is closure of the fistula. This can be achieved with various surgical methods, such as the Clagett or accelerated Weder procedure, omentoplasty, or a transpericardial approach, according to Abruzzini. We present the case of a 58-year-old patient with pleural empyema within the postpneumonectomy cavity in the presence of severe COVID-19 pneumonia after non-COVID-19 acute respiratory distress syndrome (ARDS) and extracorporeal membrane oxygenation (ECMO) therapy. The patient had undergone right-sided pneumonectomy for destroyed lung syndrome after invasive pulmonary aspergillosis.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- coronavirus disease
- sars cov
- respiratory failure
- mechanical ventilation
- case report
- respiratory syndrome coronavirus
- stem cells
- pulmonary hypertension
- intensive care unit
- public health
- ultrasound guided
- early onset
- risk factors
- bone marrow
- type diabetes
- coronary artery disease
- global health
- drug induced
- combination therapy
- cell therapy
- community acquired pneumonia